V. Ferré

发表

Apoptosis characterizes immunological failure of HIV infected patients

Damien Ernst, Raphaël Fonteneau, Guy-Bart Stan, 2009 .

Mathematical Modeling of HIV Dynamics After Antiretroviral Therapy Initiation: A Review

Xiaohua Xia, Damien Ernst, Guy-Bart Stan, 2014, BioResearch open access.

Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.

Jacques Barbet, Françoise Roquet, Daniel Baty, 2007, Molecular immunology.

Seroprevalence and Molecular Characterisation of Human Hepatitis A virus in Serum Samples of Tunisian Patients with Clinical Symptoms of Viral Hepatitis

M. Aouni, N. Abid, S. Billaudel, 2012, Indian Journal of Virology.

Genetic analysis of hepatitis a virus outbreak in france confirms the co‐circulation of subgenotypes Ia, Ib and reveals a new genetic lineage

M. Costa-Mattioli, B. Besse, S. Billaudel, 2001, Journal of medical virology.

Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

C. Charpentier, B. Masquelier, J. Izopet, 2010, Antimicrobial Agents and Chemotherapy.

Efficacy and Tolerability of a Nucleoside Reverse Transcriptase Inhibitor-Sparing Combination of Lopinavir/Ritonavir and Efavirenz in HIV-1-Infected Patients

F. Raffi, C. Michelet, C. Brunet-François, 2005, Journal of acquired immune deficiency syndromes.

Mathematical modeling of HIV dynamics after antiretroviral therapy initiation: a clinical research study.

D. Ernst, C. Moog, R. Fonteneau, 2014, AIDS Research and Human Retroviruses.

Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables.

O. Traoré, B. Lombard, C. Burger, 2006, International journal of food microbiology.

Detection and quantification by real-time RT-PCR of hepatitis A virus from inoculated tap waters, salad vegetables, and soft fruits: characterization of the method performances.

C. Burger, V. Ferré, S. Perelle, 2007, International journal of food microbiology.

An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains

B. Imbert-Marcille, F. Raffi, B. Besse, 2017, PloS one.

Clearance of Human-Pathogenic Viruses from Sludge: Study of Four Stabilization Processes by Real-Time Reverse Transcription-PCR and Cell Culture

S. Billaudel, V. Ferré, A. Maul, 2004, Applied and Environmental Microbiology.

Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.

V. Ferré, V. Soriano, M. Segondy, 2005, Journal of virological methods.

Quantification of human astroviruses in sewage using real-time RT-PCR.

V. Ferré, P. le Cann, S. Monpoeho, 2004, Research in microbiology.

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

V. Calvez, C. Delaugerre, S. Yerly, 2017, The Journal of antimicrobial chemotherapy.

Nevirapine–Raltegravir Combination, An Nrti and Pi/R Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients

P. Muret, B. Hoen, F. Raffi, 2013, Antiviral therapy.

Virologic Diagnosis and Follow-up of Children Born to Mothers Infected by HIV-1 Group O

V. Ferré, V. Lemée, J. Braun, 2004, Journal of acquired immune deficiency syndromes.

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.

V. Calvez, C. Delaugerre, S. Yerly, 2015, The Journal of antimicrobial chemotherapy.

Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA.

F. Raffi, P. Weinbreck, V. Ferré, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Allogenic bone marrow transplantation with a donor presenting with an acute hepatitis A.

V. Ferré, Y. Buisson, D. Ghez, 2001, Journal of hepatology.

Breakthrough infections after post-exposure vaccination against Monkeypox

C. Charpentier, Y. Yazdanpanah, V. Ferré, 2022, medRxiv.

Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study).

V. Calvez, F. Raffi, V. Ferré, 2007, The Journal of infection.

Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

E. Vicaut, F. Raffi, L. Flet, 2021, Trials.

Decrease of enteric micro‐organisms from rural sewage sludge during their composting in straw mixture

P. Morand, S. Billaudel, V. Ferré, 2005, Journal of applied microbiology.

Land application and composting: a comparative sanitary study of two routes of sludge

P. Morand, V. Ferré, M. Federighi, 2005 .

Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre‐emptive therapy

B. Besse, V. Ferré, C. Bressollette-Bodin, 2009, Journal of medical virology.

Salvage Therapy with Ritonavir-Boosted Amprenavir/Fosamprenavir: Virological and Immunological Response in Two Years Follow-up

F. Raffi, V. Ferré, B. Bonnet, 2005, HIV clinical trials.

Genetic variability of hepatitis A virus.

M. Costa-Mattioli, S. Billaudel, V. Ferré, 2003, The Journal of general virology.

Viral and clinical factors associated with the fulminant course of hepatitis A infection

D. Samuel, H. Bismuth, C. Féray, 2003, Hepatology.

The Virgo Study: Nevirapine, Didanosine and Stavudine Combination Therapy in Antiretroviral-Naive HIV-1-Infected Adults

W. Rozenbaum, F. Raffi, V. Ferré, 1999, Antiviral therapy.

Prolonged hepatitis A infection in an HIV‐1 seropositive patient

A. Poirier, M. Costa-Mattioli, F. Raffi, 2002, Journal of medical virology.

Genetic variability of hepatitis A virus in South America reveals heterogeneity and co-circulation during epidemic outbreaks.

M. Costa-Mattioli, S. Billaudel, V. Ferré, 2001, The Journal of general virology.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study

V. Calvez, C. Charpentier, C. Delaugerre, 2017, The Journal of antimicrobial chemotherapy.

Quantification and duration of viraemia during hepatitis A infection as determined by real‐time RT‐PCR

M. Costa-Mattioli, S. Billaudel, V. Ferré, 2002, Journal of viral hepatitis.

Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells.

V. Ferré, D. Heymann, F. Blanchard, 2009, Bone.

Evidence of recombination in natural populations of hepatitis A virus.

D. Casane, M. Costa-Mattioli, S. Billaudel, 2003, Virology.

Molecular Evolution of Hepatitis A Virus: a New Classification Based on the Complete VP1 Protein

H. Romero, D. Casane, M. Costa-Mattioli, 2002, Journal of Virology.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.

C. Charpentier, F. Raffi, G. Peytavin, 2020, International journal of antimicrobial agents.

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

Y. Yazdanpanah, J. Timsit, F. Raffi, 2021, Proceedings of the National Academy of Sciences.

Application of a Real-Time Polymerase Chain Reaction with Internal Positive Control for Detection and Quantification of Enterovirus in Cerebrospinal Fluid

M. Costa-Mattioli, B. Besse, S. Billaudel, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018.

C. Charpentier, R. Tubiana, C. Katlama, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study.

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).

V. Calvez, D. Podzamczer, C. Delaugerre, 2020, The Journal of antimicrobial chemotherapy.

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Hepatitis A in Tunisia: phylogenetic analysis of hepatitis A virus from 2001 to 2004.

M. Aouni, S. Billaudel, V. Ferré, 2006, Journal of virological methods.

Residual viremia in patients on antiretroviral therapy incorporating nevirapine is not associated with the gag‐specific cellular immune response

F. Raffi, V. Ferré, C. Allavena, 2014, Journal of medical virology.

The Immune Response to the RT181-189 Epitope in HIV-1-Infected Patients is Associated with Viral Sequence Polymorphism Flanking the Epitope

T. Harrer, F. Raffi, V. Ferré, 2011, Journal of Clinical Immunology.

Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy.

F. Raffi, V. Ferré, D. Boutoille, 2018, Journal of virological methods.

Genotypic Determinants of the Virological Response to Tenofovir Disoproxil Fumarate in Nucleoside Reverse Transcriptase Inhibitor-Experienced Patients

F. Brun-Vézinet, B. Masquelier, D. Costagliola, 2003, Antiviral therapy.

A 1-year study of the epidemiology of hepatitis A virus in Tunisia.

M. Aouni, S. Billaudel, V. Ferré, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Characterization of outbreak hepatitis a isolates in five Tunisian childcare centers

M. Aouni, S. Billaudel, V. Ferré, 2011, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR.

V. Maréchal, J. Nicolas, L. Schwartzbrod, 2000, BioTechniques.

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study

F. Raffi, L. Flet, V. Ferré, 2021, medRxiv.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

V. Calvez, C. Delaugerre, S. Yerly, 2013, International journal of antimicrobial agents.

Best Viral Elution Method Available for Quantification of Enteroviruses in Sludge by Both Cell Culture and Reverse Transcription-PCR

L. Schwartzbrod, S. Billaudel, V. Ferré, 2001, Applied and Environmental Microbiology.

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

A. Plet, F. Raffi, V. Ferré, 2011, AIDS.

Seroprevalence and Molecular Characterisation of Human Hepatitis A virus in Serum Samples of Tunisian Patients with Clinical Symptoms of Viral Hepatitis

M. Aouni, S. Billaudel, V. Ferré, 2012, Indian Journal of Virology.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.

V. Calvez, C. Charpentier, C. Delaugerre, 2012, The Journal of antimicrobial chemotherapy.

Algorithm-Based Prediction of HIV-1 Subtype D Coreceptor Use

J. Izopet, V. Ferré, S. Raymond, 2013, Journal of Clinical Microbiology.

Virological response to darunavir in patients infected with HIV is linked to darunavir resistance–associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacological parameters

P. Jolliet, F. Raffi, V. Ferré, 2012, Fundamental & Clinical Pharmacology.

R57K Polymorphism in the Human Immunodeficiency Virus Type 1 Protease as Predictor of Early Virological Failure in a Cohort of Antiretroviral-Naive Patients Treated Mostly with a Nelfinavir-Containing Regimen

B. Masquelier, F. Raffi, B. Spire, 2003, Antimicrobial Agents and Chemotherapy.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV‐infected adults on a long‐term non‐nucleoside reverse transcriptase inhibitor‐based regimen

F. Raffi, V. Ferré, V. Reliquet, 2013, Journal of medical virology.

Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2020, The Journal of antimicrobial chemotherapy.

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, BMC Infectious Diseases.

Genetic analysis of HAV strains in Tunisia reveals two new antigenic variants

M. Aouni, S. Billaudel, V. Ferré, 2007, Virus Genes.

No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study.

C. Katlama, Y. Yazdanpanah, E. Delaporte, 2021, Journal of Antimicrobial Chemotherapy.

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.

V. Calvez, C. Delaugerre, S. Yerly, 2008, Journal of Antimicrobial Chemotherapy.

Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial

C. Katlama, Y. Yazdanpanah, F. Raffi, 2021, AIDS Research and Therapy.

Genetic variability of hepatitis A virus in South America reveals heterogeneity and co-circulation during epidemic outbreaks.

S. Billaudel, V. Ferré, R. Perez-Bercoff, 2001, The Journal of general virology.